Is iohexol a sufficient alternative to barium sulfate for adult videofluoroscopy swallowing studies? A feasibility study

Tracks
Digital posters
Adult
Quality improvement
Service delivery
Swallowing
VFSS (videofluroscopy)
Tuesday, May 28, 2024
1:50 PM - 2:05 PM
Knowledge Hub

Overview

Kiara Tatt


Presenter

Agenda Item Image
Miss Kiara Tatt
Royal Melbourne Hospital

Is iohexol a sufficient alternative to barium sulfate for adult videofluoroscopy swallowing studies? A feasibility study

1:50 PM - 2:05 PM

Presentation summary

Videofluoroscopy is considered one of the gold standard tools for evaluating swallowing disorders. Barium sulfate is the traditional contrast used however due to a nationwide shortage, alternative contrast agents have required exploration. The aim of this project was to investigate whether iohexol was a comparable videofluoroscopy swallowing contrast to barium sulfate from the perspective of 1) Diagnostic visibility and 2) Useability/feasibility. Fifteen clinicians were presented with 294 videofluoroscopy swallow trials of varying food and fluid consistencies and blinded to the contrast used. The clinicians were required to make a judgement regarding satisfaction with contrast visibility using a 5-point Likert scale (1 = very unsatisfied to 5 = very satisfied). A subset of eligible clinicians were also asked to complete a qualitative survey regarding their experience with both contrasts. Data was descriptively analysed to determine if there is a difference in the Likert rankings of satisfaction between the two contrasts based on food/fluid consistency, oral/pharyngeal phase and lateral/anterior-posterior view. The qualitative survey data was analysed thematically. Preliminary analysis indicates that satisfaction with contrast visibility overall between the two contrasts is comparable however there appears to be some within consistency differences. 85% of clinicians were satisfied or very satisfied with the visibility of iohexol when mixed with fluids in comparison to barium (82%); whereas 83% of clinicians were satisfied or very satisfied with the visibility of barium when mixed with solids in comparison to iohexol (63%). The thematic analysis also revealed a contrast preference however this was related to preparation time as a strong deciding factor. These findings will aid in the development of an evidence base for the use of iohexol in videofluoroscopy swallowing studies and guide clinical decision-making regarding contrast choice.

Key messages

1. Iohexol is a comparable contrast to barium however there are particular situations and scenarios where one is preferenced over another.
2. In light of this we would encourage you to think more broadly regarding contrast use in videofluoroscopy swallowing studies by considering both patient characteristics and the clinical factors that led you to conduct a videofluoroscopy in the first instance and matching these with the contrast.
3. Finally, further development of iohexol recipes would be of benefit as the primary barrier was related to the time required to prepare the food and fluid trials.

**********

Kiara Tatt is a speech pathologist with a passion for working within the neuroscience caseload and providing patient-centered care. Kiara has worked at the Royal Melbourne Hospital (RMH) since 2018 and is currently working with patients across the continuum of care.
Michelle Lin

Is iohexol a sufficient alternative to barium sulfate for adult videofluoroscopy swallowing studies? A feasibility study

1:50 PM - 2:05 PM

**********

Michelle Lin holds a Masters in Speech Pathology and Bachelors in Biomedicine. She has extensive experience in Speech Pathology management across the continuum of care and is passionate about using digital health to optimise healthcare.

SPA staff

Agenda Item Image
Nadia Marussinszky
Ethics Advisor, Speak Up Podcast Co-producer
Speech Pathology Australia


Student volunteer(s)

Agenda Item Image
Rania Atee
Curtin University

The information contained in this program is current at of the time of publishing but is subject to changes made without notice.

Disclaimer: © (2024) The Speech Pathology Association of Australia Limited. All rights reserved.
Important Notice, please read: The views expressed in this presentation and reproduced in these materials are not necessarily the views of, or endorsed by, The Speech Pathology Association of Australia Limited ("the Association"). The Association makes no warranty or representation in relation to the content, currency or accuracy of any of the materials comprised in this presentation. The Association expressly disclaims any and all liability (including liability for negligence) in respect of use of these materials and the information contained within them. The Association recommends you seek independent professional advice prior to making any decision involving matters outlined in this presentation including in any of the materials referred to or otherwise incorporated into this presentation.

 

© Copyright 2024 Speech Pathology Australia


We acknowledge the Traditional Custodians of 
lands, seas and waters throughout Australia,
and pay respect to Elders past, present and
future.

We recognise that the health and social and
emotional wellbeing of Aboriginal and Torres
Strait Islander peoples are grounded in
continued connection to Culture, Country,
Language and Community and acknowledge
that sovereignty was never ceded. 

    Torres Strait Islander flag

.

              

loading